Allerphast 180mg Mebiphar medicine for seasonal allergic rhinitis, indefinite urticaria (1 blister x 10 tablets)
Dosage form Film bag tablets
Specifications Box of 1 blister x 10 tablets
Ingredient Fexofenadin hydrochlorid
Ingredient
| Composition information | Content |
| Fexofenadin hydrochlorid | 180mg |
Uses
Indications
allerphast is indicated in case:
The drug is a metabolic substance of terfenadin, also competing with histamine at H1 receptors in the digestive tract, blood vessels and respiratory tract, but no toxicity for the heart due to not inhibiting potassium channels associated with myocardial cycle.
Fexofenadin has no significant effect on acetylcholin antagonism, dopamine antagonism and has no effect on receptor inhibiting Alpha1 or Beta - Adrenergic.
In the treatment dose, the drug does not cause sleep or affects the central nervous system. The drug has a fast and prolonged effect due to slow -attached drugs into H1 receptors, forming a sustainable complex and slowly separated.
Pharmacokinetics
absorption
Good absorption drug when taken oral and start to work after drinking 60 minutes. The peak concentration in the blood is achieved after 2-3 hours. Fat -rich foods reduce the peak concentration in plasma by about 17% and extend the time to reach the peak concentration of the drug (until about 4 hours). Anti -antihistamine effect lasts more than 12 hours.
Distribution
The ratio of the plasma protein of the drug is 60 - 70%, mainly with albumin and alpha1 - Glycoprotein acid. It is unclear whether the drug will be through the placenta or excreted into breast milk. Fexofenadin does not pass the blood - brain barrier.
Metabolism
Fexofenadin is very little metabolized.
Elimination
FEXOFENADIN SELLING Time is about 14.4 hours, longer (31 - 72%) in kidney failure people. The drug excreted mainly in feces (approximately 80%) and urine (11 - 12%) in constant form.
Before taking Allerphast 180mg Mebiphar medicine for seasonal allergic rhinitis, indefinite urticaria (1 blister x 10 tablets)
How to use
oral medication.
Dosage
Allergic rhinitis
Children from 6 - 12 years: 30 mg x 2 times/day, should be used with lower content to match this dose.
Standing chronic urticaria
People with kidney failure
Hepatic impairments
No dose adjustment.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose? However, drowsiness, dizziness, dry mouth have been reported.
Handling: Using conventional measures to remove the drug that has not been absorbed in the digestive tract. Support support and symptomatic treatment. Hemolysis is negligible in blood concentration (1.7%). There is no specific antidote.
In an emergency, call the 115 emergency center immediately or go to the nearest local health station.
What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not use double the prescribed dose.
Side Effects
When using Allerphast 180 mg often has unwanted effects (ADR).
Common, ADR> 1/100
Uncommon, 1/1000 Rare, ADR Instructions on how to handle ADR When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
contraindicated
Allerphast is contraindicated in the following cases:
Be cautious when using
Although there is no toxicity on the heart like Terfenadin, but still be cautious when taking drugs for people who are at risk of cardiovascular or have a long -lasting QT range.
Caution and use of appropriate doses for patients with impaired renal function due to increased plasma drug concentration due to prolonged sale time.
Patients should not use other antihistamine drugs while using fexofenadin.
Safety and effectiveness of drugs for children under 6 years old have not been determined.
It is necessary to stop using fexofenadin at least 24 - 48 hours before conducting skin injection tests.
The ability to drive and operate machinery
The drug is less likely to affect the ability to drive and operate machinery. However, it is necessary to check the personal reaction before driving or perform complex tasks to detect people who are sensitive to the drug.
Pregnancy
There is no full research on pregnant people, so only use fexofenadin for pregnant women when the maternal benefits are superior to the risk for the fetus.
The period of breastfeeding
has not clearly defined whether the drug is excreted through breast milk or not, so it is necessary to be cautious when taking the drug for breastfeeding women.
Drug interaction
erythromycin and ketoconazole increases the concentration and time of fexofenadin in the blood, but this interaction has no clinical significance.
Antacuric antacids containing aluminum and magnesi if used simultaneously with fexofenadin will reduce the absorption of the drug, so they must use these drugs about 2 hours apart.
Storage
Avoid light and moist, temperatures below 30 ° C.
Other drugs
- CLEXANE 60MG/0.6ML SYRINGES
- ESPUMISAN 100 MG/1ML ORAL DROPS EMULSION
- LANSOPRAZOL 30 MG CAPSULES GASTRO-RESISTANT CAPSULES
- PRIADEL 400MG TABLETS
- THADEN CAPSULES 25MG
- UTROGESTAN 100MG CAPSULES
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions